Clinical effects and safety of Compound Glutamine Entersoluble Capsules for diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis
Journal article
Liang, S-B., Liang, C-H., Yang, S-H., Li, Y-Q., Tian, Z-Y., Robinson, N. and Liu, J. (2019). Clinical effects and safety of Compound Glutamine Entersoluble Capsules for diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis. European Journal of Integrative Medicine. https://doi.org/10.1016/j.eujim.2019.101005
Authors | Liang, S-B., Liang, C-H., Yang, S-H., Li, Y-Q., Tian, Z-Y., Robinson, N. and Liu, J. |
---|---|
Abstract | Introduction: Diarrhea-predominant irritable bowel syndrome (IBS-D) is a gastrointestinal disease with a high incidence and no effective drugs available. Compound Glutamine Entersoluble Capsules (CGEC) is a compound preparation integrating Sijunzi Decoction and L-Glutamine. The aim of this systematic review was to evaluate the clinical effects and safety of CGEC for IBS-D. |
Year | 2019 |
Journal | European Journal of Integrative Medicine |
Publisher | Elsevier |
ISSN | 1876-3820 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.eujim.2019.101005 |
Publication dates | |
Online | 06 Nov 2019 |
Publication process dates | |
Accepted | 04 Nov 2019 |
Deposited | 13 Nov 2019 |
Accepted author manuscript | License File Access Level Open |
https://openresearch.lsbu.ac.uk/item/88775
Download files
Accepted author manuscript
Revision3-EuJIM-Manuscript-1.docx | ||
License: CC BY-NC-ND 4.0 | ||
File access level: Open |
189
total views60
total downloads10
views this month0
downloads this month